Novartis ranks first in 2024 Access to Medicine Index
Novartis ranks first in 2024 Access to Medicine Index
arcticnovartis
- The Index spotlights Novartis leadership in research and development, and governance of access, with Novartis ranking first in these sub-topics
- Novartis malaria access plans, widespread registration of products in LMICs, and inclusive business model to improve access to products in multiple countries were all highlighted as Best Practice across the industry
- Novartis has risen three places to secure the top spot on the 2024 Access to Medicine Index